![glp 1 cardiac protection Cardiovascular disease continuum-GLP-1 action. Adapted from [46] JCI - Cardioprotective GLP-1 metabolite](https://www.researchgate.net/publication/357072789/figure/fig1/AS:1146405179654167@1650335702879/Cardiovascular-disease-continuum-GLP-1-action-Adapted-from-46.png)
glp 1 cardiac protection Cardiovascular disease continuum-GLP-1 action. Adapted from [46] JCI - Cardioprotective GLP-1 metabolite
Description
Many drugs are in the pipeline for the treatment of NAFLD/NASH, and several glucose-lowering drugs are now being tested specifically for the treatment of liver disease
![glp 1 cardiac protection Cardiovascular disease continuum-GLP-1 action. Adapted from [46] JCI - Cardioprotective GLP-1 metabolite](https://dm5migu4zj3pb.cloudfront.net/manuscripts/99000/99934/medium/JCI99934.ga.jpg)
Read here @AmDiabetesAssn @ADA_DiabetesPro @ADA_Pubs
![glp 1 cardiac protection Cardiovascular disease continuum-GLP-1 action. Adapted from [46] JCI - Cardioprotective GLP-1 metabolite](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12170-025-00761-0/MediaObjects/12170_2025_761_Fig1_HTML.png)
Noom makes it last.
![glp 1 cardiac protection Cardiovascular disease continuum-GLP-1 action. Adapted from [46] JCI - Cardioprotective GLP-1 metabolite](https://wordpress.myaster.com/wp-content/uploads/2025/10/glp-medication.jpg)
Finally, a weight loss approach that works with your biology.
![glp 1 cardiac protection Cardiovascular disease continuum-GLP-1 action. Adapted from [46] JCI - Cardioprotective GLP-1 metabolite](https://ars.els-cdn.com/content/image/1-s2.0-S2095177923002903-ga1.jpg)
Effortlessly combat cravings and dissolve stubborn fat while you sleep with Night Shred GLP-1
![glp 1 cardiac protection Cardiovascular disease continuum-GLP-1 action. Adapted from [46] JCI - Cardioprotective GLP-1 metabolite](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12933-025-02607-w/MediaObjects/12933_2025_2607_Fig1_HTML.png)
This review examines the effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on different heart failure phenotypes with preserved ejection fraction
![glp 1 cardiac protection Cardiovascular disease continuum-GLP-1 action. Adapted from [46] JCI - Cardioprotective GLP-1 metabolite](https://www.researchgate.net/publication/394539211/figure/fig2/AS:11431281625829351@1757326320475/The-effects-of-cardiac-protection-mediated-by-GLP-1-RA-include-multiple-physiological_Q320.jpg)
